β -Amyloid: A Disease Target or a Synaptic Regulator Affecting Age-Related Neurotransmitter Changes?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|6|672-683

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.6, 2010-02, pp. : 672-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Age-Related Changes in Pharmacokinetics

By  

Current Drug Metabolism, Vol. 12, Iss. 7, 2011-09 ,pp. : 601-610

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 699-704

Bentham Science Publishers

Access to resources Recommend Favorite

Age-Related Changes in Wound Healing

By Thomas D.R.  

Drugs & Aging, Vol. 18, Iss. 8, 2001-08 ,pp. : 607-620

Adis International

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Elevated Plasma Levels of  -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimer's Disease: A Potential Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 14, Iss. 26, 2008-09 ,pp. : 2659-2664

Bentham Science Publishers

Access to resources Recommend Favorite